Introducing HekaFlo by Heka Medicals India Pvt. Ltd., the leading manufacturer and global supplier of High Flow Nasal Cannula (HFNC) Systems in India. Our innovative high-flow nasal oxygen therapy system, HekaFlo, is designed to provide optimal respiratory support to hypoxic patients who are spontaneously breathing. With its ability to deliver 100% humidified and heated oxygen at a flow rate of up to 60 liters per minute, HekaFlo has proven to be highly effective in treating patients with respiratory distress caused by hypoxemia, particularly those infected with COVID-19.
HekaFlo is specifically developed to address acute hypoxemic respiratory failure, making it an ideal solution for COVID-19 patients and individuals with hypoxia. Unlike traditional oxygen therapy, which offers flow rates of up to 15 liters per minute, HekaFlo’s high flow oxygen therapy based on HFNO can provide flow rates of up to 60 liters per minute. This significant increase in flow rate allows for higher FiO2 levels, ensuring optimal oxygenation for patients in need.
One of the key advantages of HekaFlo is its ability to deliver oxygen at high flows while maintaining patient comfort. The gas is heated and humidified, preventing mucosal injury and discomfort that can be associated with high flow rates. This breakthrough technology overcomes long-standing challenges associated with high flow rates, making HekaFlo a superior choice for respiratory support.
At Heka Medicals India Pvt. Ltd., we understand the importance of local SEO optimization to reach our target audience effectively. Therefore, we have incorporated local SEO keywords for various cities to ensure that our product description reaches the right audience in their respective regions. By including these keywords, such as “High Flow Nasal Cannula in Mumbai,” “HFNC Systems in Delhi,” and “Respiratory Support in Bangalore,” we aim to enhance our online visibility and connect with potential customers in these cities.
In conclusion, HekaFlo by Heka Medicals India Pvt. Ltd. is a game-changing high-flow nasal oxygen therapy system that offers unparalleled respiratory support for hypoxic patients. With its ability to deliver 100% humidified and heated oxygen at a flow rate of up to 60 liters per minute, HekaFlo is revolutionizing the treatment of acute hypoxemic respiratory failure, particularly in COVID-19 patients. Experience the difference with HekaFlo and ensure optimal oxygenation for your patients. Contact us today to learn more about our innovative HF
Reviews
There are no reviews yet.